رفتن به محتوا

تداخل‌های دارویی

Dihydroergotamine intranasal + Sumatriptan

شدت: منع مصرف

Dihydroergotamine intranasal and Sumatriptan: contraindicated interaction.

آخرین به‌روزرسانی

ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.

محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.

خلاصه

Both drugs constrict blood vessels, and the systemic absorption of intranasal dihydroergotamine is sufficient for additive prolonged vasospasm with risk of coronary or peripheral ischemia. Labeling prohibits use of triptans and ergot derivatives within 24 hours of each other.

معنای این تداخل به زبان ساده

Dihydroergotamine intranasal and Sumatriptan are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

سطح شواهد: High

چرا رخ می‌دهد

Additive vasoconstriction via 5-HT1B/1D agonism by sumatriptan and serotonergic and adrenergic vasoconstriction by dihydroergotamine.

اقدام لازم

Do not use within 24 hours of each other. Choose one agent for each migraine episode and observe the timing interval.

از داروساز چه بپرسید

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

ویژه اعضای Pro+

باز کردن کل صفحه

یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Dihydroergotamine intranasal و Sumatriptan، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.

پرسش‌های متداول

Can I take Dihydroergotamine intranasal with Sumatriptan?

MediHelp rates the interaction as contraindicated. Dihydroergotamine intranasal and Sumatriptan are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Both drugs constrict blood vessels, and the systemic absorption of intranasal dihydroergotamine is sufficient for additive prolonged vasospasm with risk of coronary or peripheral ischemia. Labeling prohibits use of triptans and ergot derivatives within 24 hours of each other.

How serious is the interaction between Dihydroergotamine intranasal and Sumatriptan?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not use within 24 hours of each other. Choose one agent for each migraine episode and observe the timing interval.

What other medicines interact with Sumatriptan?

MediHelp also lists interactions of Sumatriptan with, for example, Almotriptan, Dihydroergotamine, Eletriptan. The full list is on the Sumatriptan page.

تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp

مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.

مرور از A تا Z · تداخل‌های دارویی

دریافت برنامه ورود